Idorsia Ltd
OTC:IDRSF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Idorsia Ltd
OTC:IDRSF
|
CH |
|
P
|
Parpro Corp
TWSE:4916
|
TW |
|
Saga Pure ASA
F:SAT
|
NO |
|
D
|
Dohome PCL
SET:DOHOME
|
TH |
|
IPE Universal Inc
OTC:IPEU
|
US |
|
Triad Group PLC
F:TD8
|
UK |
|
Noritsu Koki Co Ltd
TSE:7744
|
JP |
|
Fonterra Co-Operative Group Ltd
NZX:FCG
|
NZ |
|
Envy Technologies Indonesia Tbk PT
IDX:ENVY
|
ID |
|
A
|
American Tower Corp
F:A0T
|
US |
|
C
|
Cleveland-Cliffs Inc
BMV:CLF
|
US |
|
Tokai Senko KK
TSE:3577
|
JP |
Intrinsic Value
Is IDRSF undervalued or overvalued?
See the intrinsic value estimate for 
Idorsia Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
IDRSF looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with IDRSF’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Idorsia Does
Idorsia is a Swiss biopharmaceutical company that discovers and develops prescription medicines. It focuses on diseases where patients need new treatment options, especially sleep disorders, high blood pressure, and some immune and nervous system conditions. The company’s work is centered on creating new drug candidates, testing them in clinical trials, and getting them approved for sale.
- Headquarters
- Switzerland CH
- Employees
- 456
- IPO date
- Jun 16, 2017
Earnings Waterfall
Idorsia Ltd
The intrinsic value for Idorsia Ltd (IDRSF) under the Base Case is hidden USD.
Compared with the current market price of 5.38 USD, the stock appears hidden.